FDA asks Vivus to study diet drug, birth defects
Vivus and rival Arena Pharmaceuticals Inc. had their diet drugs rejected by the agency in October, as competitor Orexigen Therapeutics Inc.'s weight–loss …
See all stories on this topic »
Good Health is Your Greatest Wealth……Virgil
Vivus and rival Arena Pharmaceuticals Inc. had their diet drugs rejected by the agency in October, as competitor Orexigen Therapeutics Inc.'s weight–loss …
See all stories on this topic »